| Name | Title | Contact Details |
|---|
Established in 1946 as well as being family owned and operated since 1946, the Fletcher Jones Company has grown into one of the largest and most respected automotive groups in the world. Our Preferred Owner Benefits include many amenities such as a complimentary Mercedes-Benz courtesy vehicle and a complimentary hand car wash.
OPTIMIZED FLEETS. LOWER COSTS. ONE STRATEGIC PARTNER. As a strategic, brand-independent consulting partner we focus on empowering businesses to optimize their fleet management practices through: ✔Cutting-edge cost-saving initiatives ✔Real-time data analytics ✔Streamlined vendor management ✔Seamless intralogistics ✔Safeguarding assets and workforce ✔Increasing financial capacity ✔Optimizing efficiencies ✔Implementing responsible & sustainable practices Lets partner and find ways to optimize your fleet, experience 15x ROI, and drive operational efficiencies. Learn more at www.fleetteam.com
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Zurn Elkay Water Solutions supplies the industrys widest range of clean water solutions for drinking water, hygiene and sustainable water management. Headquartered in Milwaukee, Wisconsin, Zurn Elkay works with customers around the globe to deliver products and systems that enhance and ensure water quality, safety, hygiene, flow control and conservation. From healthcare to hospitality, education to retail and residential to office facilities, we pride ourselves on meeting specialized needs for every market, focusing on quality, reliability, quick installation and easy maintenance. Our values of Continuous Improvement, Integrity in Everything We Do, Customer First, Culture of Winning, and Total Associate Engagement serve as our drive to achieve world-class safety, quality, delivery, cost and growth now and in the future. In everything we do, we are sustainably inspired. We work to make our communities better with volunteerism and philanthropy, and support diversity, equity and inclusion inside and outside our walls. We seek to uphold our promise to the planet every day by providing sustainable water management solutions.